SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRentokil Initial Regulatory News (RTO)

Share Price Information for Rentokil Initial (RTO)

Share Price is delayed by 15 minutes
Get Live Data
453.60    3.80 (0.84%)
Bid:
452.90
Ask:
453.20
Spread: 0.30 (0.066%)
Market Cap: £11.41b
RTO Live PriceLast checked at - London Stock Exchange

Intraday Rentokil Initial Share Chart

Acquisition

28 Aug 2015 07:07

RNS Number : 4055X
Rentokil Initial PLC
28 August 2015
 



28 August 2015

Acquisition of Anderson Pest Solutions, USA

 

Rentokil Initial plc (FTSE: RTO, "the Company") announces the continued expansion of its pest control business with the acquisition of Chicago-based Anderson Pest Solutions ("Anderson"). Its annualised revenues for the 12 months prior to acquisition were $21m.

 

The acquisition is in line with the Company's strategy of continued acceleration of its pest control business and pursuing acquisition targets in higher growth markets. It also builds customer density, primarily in the Chicago metropolitan area.

Andy Ransom, Chief Executive of Rentokil Initial plc, said:

"We are delighted to join forces with Anderson Pest Solutions in the Chicago area. It is a well-established and highly respected business, and with long-term customer relationships.

"With an 80% commercial portfolio, areas of potential growth include introducing additional services such as Rentokil's bird control and bioremediation expertise to Anderson's customer base, but also the benefits that Anderson's particular expertise in eco-effective pest control will bring to us.

"North America is an important growth market for the Company and our pipeline of acquisitions in pest control remains strong as we expect to continue the acceleration in pest control and deliver the next phase in our plan for profitable growth."

 

Rentokil North America Strategy and Performance

· North America is a key strategic market in our Growth quadrant.

· As set out in the recent Rentokil Pest Control seminar, North America is the largest pest control market worldwide, with an estimated growth rate of ~3.5% in 2014.

· The Company's strategy for strong growth and rising margins in North America is to: increase scale in commercial pest control; drive profitability through route density building by the in-fill of areas with lower customer penetration; extend coverage and capability for national accounts; accelerate growth through M&A; and target local organic growth using the Rentokil model of targeted sales activity, upselling additional services, investment in brand building and high standards of customer satisfaction leading to customer retention.

· In the first six months of 2015, Rentokil Initial's North America region revenue grew 8.3%, with strong profit growth of 19.5% driven by acquisitions and leverage impact from higher revenues.

 

ENDS

 

Investor / Analyst enquiries:

Katharine Rycroft, Investor Relations, Rentokil Initial plc 07811 270 734

 

Media enquiries:

Malcolm Padley, Corporate Communications, Rentokil Initial plc 07788 978 199

 

About Rentokil Initial plc

Rentokil Initial is one of the largest business services companies in the world, operating in over 60 countries. The Company offers route-based services including Pest Control, Hygiene and Workwear through teams of local experts.

www.rentokil-initial.com

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
ACQUWUVRVWAWURR
Date   Source Headline
21st May 20267:00 amRNSAppointment of CEO, North America
8th May 202610:30 amRNSHolding(s) in Company
7th May 20264:40 pmRNSResult of AGM
23rd Apr 20264:25 pmRNSFinal Dividend – Pence Sterling Amount Payable
23rd Apr 20262:30 pmRNSIssuance of $500 million 4.625% Notes due 2031
21st Apr 202610:30 amRNSHolding(s) in Company
16th Apr 20267:00 amRNSQ1 Trading Update
15th Apr 20267:00 amRNSDirectorate Change
30th Mar 202610:30 amRNSHolding(s) in Company
26th Mar 20263:46 pmRNSDirector/PDMR Shareholding
25th Mar 202610:50 amRNSAnnual Financial Report
17th Mar 20264:30 pmRNSDirector/PDMR Shareholding
16th Mar 202610:32 amRNSHolding(s) in Company
16th Mar 202610:32 amRNSHolding(s) in Company
12th Mar 202610:30 amRNSHolding(s) in Company
10th Mar 20264:28 pmRNSDirector/PDMR Shareholding
10th Mar 20264:28 pmRNSDirector/PDMR Shareholding
10th Mar 20264:26 pmRNSDirector/PDMR Shareholding
10th Mar 20264:26 pmRNSDirector/PDMR Shareholding
9th Mar 202611:15 amRNSHolding(s) in Company
5th Mar 20267:00 amRNSPreliminary Results
5th Mar 20267:00 amRNSChair Succession Planning Update
23rd Feb 202610:30 amRNSHolding(s) in Company
19th Feb 20262:50 pmRNSDirector Declaration
12th Feb 20265:30 pmRNSNotice of Early Redemption
20th Jan 202610:25 amRNSHolding(s) in Company
19th Jan 202610:30 amRNSHolding(s) in Company
16th Jan 20263:00 pmRNSHolding(s) in Company
14th Jan 202610:30 amRNSHolding(s) in Company
13th Jan 202610:30 amRNSHolding(s) in Company
13th Jan 20267:00 amRNSDirectorate change
19th Dec 202511:00 amRNSDirector/PDMR Shareholding
19th Dec 202511:00 amRNSDirector/PDMR Shareholding
5th Dec 202510:30 amRNSHolding(s) in Company
5th Dec 202510:30 amRNSHolding(s) in Company
26th Nov 20254:25 pmRNSHolding(s) in Company
28th Oct 202510:45 amRNSHolding(s) in Company
28th Oct 202510:45 amRNSHolding(s) in Company
27th Oct 202510:30 amRNSHolding(s) in Company
23rd Oct 202511:45 amRNSHolding(s) in Company
23rd Oct 20257:00 amRNSQ3 Trading Update
21st Oct 202510:00 amRNSHolding(s) in Company
14th Oct 202510:00 amRNSHolding(s) in Company
1st Oct 202510:30 amRNSBlock listing Interim Review
30th Sep 202510:30 amRNSCompletion of France Workwear business sale
25th Sep 20254:15 pmRNSDirector/PDMR Shareholding
24th Sep 20256:00 pmRNSDirector Declaration
26th Aug 202512:30 pmRNSInterim Dividend – Pence Sterling Amount Payable
7th Aug 202511:10 amRNSHolding(s) in Company
31st Jul 20257:00 amRNSHalf-year Report

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.